Journal of Nutrition

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Nutrition Vol. 105 No. 6 June 1975, pp. 741-758
Copyright © 1975 by American Society for Nutrition
This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tshibangu, K.
Right arrow Articles by Doumont-Meyvis, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tshibangu, K.
Right arrow Articles by Doumont-Meyvis, M.

Effects of Massive Doses of Ergocalciferol Plus Cholesterol on Pregnant Rats and Their Offspring1

Kalala Tshibangu, Karl Oosterwijck and Micheline Doumont-Meyvis

Laboratory of Gynecology and Human Reproduction, Research Unit, St-Pierre Hospital, 322 Rue Haute, 1000 Brussels, Belgium, and Laboratory of Pathological Chemistry, Faculty of Medicine, Free University of Brussels, 2 Rue Evers, 1000 Brussels, Belgium

Ergocalciferol (320,000 or 480,000 IU/kg) plus cholesterol (60 mg/kg) in olive oil solution was administered daily on 1, 2, or 4 consecutive days to pregnant rats from days 9, 10, 14, or 18 of gestation. The control animals received only olive oil. Disseminated lesions of metastic calcinosis were found in various tissues, in the coronary arteries and myocardium, in the media of the abdominal aorta, in the lung and pleura, in the gastrointestinal tract, and in the kidney. This is in contrast to the atherosclerosis described in nonpregnant rats fed a similar diet. A significant decline in maternal weight as well as a high rate of morbidity and mortality was observed. In mothers killed on day 22 of pregnancy, fetal and placental growths appeared significantly retarded, suggesting a direct effect of the steroid or its more active metabolite, 1,25-dihydroxycholecalciferol, on the fetus or the trophoblastic tissue. Fetal bone lesions associated with a generalized retardation of ossification, placental edema, or calcification accompanied by a loss of the normal structure of the placenta and degenerative manifestations at this level were observed. Moreover, we noted a striking alteration of the fetal face in 33–39% of experimental fetuses, called by us carnival fetuses.


KEY WORDS: • ergocalciferol • pregnancy • mediacalcinosis

1 Supported by grants from the Ford Foundation (no. 670-0465 A) and the Fonds de la Recherche Scientifique Médicale (no. 20401). Dr. K. Tshibangu is a recipient of the Ford Foundation fellowship.

Manuscript received 17 October 1974.





Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]